2/5
12:02 pm
irix
IRIDEX (NASDAQ:IRIX) was given a new $3.00 price target on by analysts at Industrial Alliance Securities.
Low
Report
IRIDEX (NASDAQ:IRIX) was given a new $3.00 price target on by analysts at Industrial Alliance Securities.
2/5
11:03 am
irix
IRIDEX (NASDAQ:IRIX) is now covered by analysts at Alliance Global Partners. They set a "buy" rating on the stock.
Low
Report
IRIDEX (NASDAQ:IRIX) is now covered by analysts at Alliance Global Partners. They set a "buy" rating on the stock.
2/2
07:31 am
irix
Iridex Announces Plans to Relocate Headquarters [Yahoo! Finance]
Medium
Report
Iridex Announces Plans to Relocate Headquarters [Yahoo! Finance]
2/2
07:00 am
irix
Iridex Announces Plans to Relocate Headquarters
Low
Report
Iridex Announces Plans to Relocate Headquarters
1/12
07:20 am
irix
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025 [Yahoo! Finance]
High
Report
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025 [Yahoo! Finance]
1/12
07:00 am
irix
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
High
Report
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025
12/16
04:38 pm
irix
IRIDEX (NASDAQ:IRIX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
IRIDEX (NASDAQ:IRIX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/11
07:31 am
irix
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management [Yahoo! Finance]
Medium
Report
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management [Yahoo! Finance]
12/11
07:00 am
irix
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
Medium
Report
Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse® Technology in Glaucoma Management
12/8
07:00 am
irix
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
Low
Report
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
12/5
07:00 am
irix
Iridex to Present at the Sidoti Year-End Virtual Investor Conference
Low
Report
Iridex to Present at the Sidoti Year-End Virtual Investor Conference